O-0028 * BEVACIZUMAB CONTINUATION VERSUS NO CONTINUATION AFTER FIRST-LINE CHEMO-BEVACIZUMAB THERAPY IN PATIENTS WITH METASTATIC COLORECTAL CANCER: A PHASE 3 NON-INFERIORITY TRIAL

Annals of Oncology(2013)

引用 0|浏览4
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要